Renate Wagner
Medical University of Vienna(AT)
Publications by Year
Research Areas
Cancer, Lipids, and Metabolism, Cancer, Hypoxia, and Metabolism, Peroxisome Proliferator-Activated Receptors, PI3K/AKT/mTOR signaling in cancer, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells(2009)86 cited
- → Blockade of Fatty Acid Synthase Induces Ubiquitination and Degradation of Phosphoinositide-3-Kinase Signaling Proteins in Ovarian Cancer(2011)73 cited
- → Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells(2014)62 cited
- → The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells(2010)59 cited
- → Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells(2017)57 cited
- → HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK(2016)23 cited
- Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells.(2015)
- → Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer(2020)16 cited
- → The Pharmacological or Genetic Blockade of Endogenous De Novo Fatty Acid Synthesis Does Not Increase the Uptake of Exogenous Lipids in Ovarian Cancer Cells(2021)14 cited
- → Upregulation of retinoic acid receptor‐β by the epidermal growth factor‐receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways(2007)12 cited